IMRNW - (Immuron Limited)

 IMRNWのチャート


 IMRNWの企業情報

symbol IMRNW
会社名
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種   
概要 事業概要 --     Immuron Ltd. engages in the research and development of oral immunotherapy, and product sales which focuses on bovine-colostrum with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. It operates through the following segments: Research and Development, and HyperImmune Products.The Research and Development segment involves the R&D projects performed in Australia, Israel, and United States. The HyperImmune Products segment comprises of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994 and is headquartered in Carlton, Australia.
本社所在地 --
代表者氏名
代表者役職名
電話番号
設立年月日 --
市場名 --
ipoyear 2017年
従業員数 -
url
nasdaq_url https://www.nasdaq.com/symbol/imrnw
adr_tso
EBITDA EBITDA ー
終値(lastsale) 2.5
時価総額(marketcap) 0
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 IMRNWのテクニカル分析


 関連キーワード  (― 米国株 IMRNW Immuron Limited)

 twitter  (公式ツイッターやCEOツイッターなど)